FoxP1 orchestration of ASD-relevant signaling pathways in the striatum

Genes and Development

Volumn 29, Issue 20, 2015, Pages 2081-2096

  Araujo, Daniel J ^a   Anderson, Ashley G ^a   Berto, Stefano ^a   Runnels, Wesley ^a   Harper, Matthew ^a   Ammanuel, Simon ^a   Rieger, Michael A ^b,c   Huang, Hung Chung ^a,d   Rajkovich, Kacey ^a   Loerwald, Kristofer W ^a   Dekker, Joseph D ^e   Tucker, Haley O ^e   Dougherty, Joseph D ^b,c   Gibson, Jay R ^a   Konopka, Genevieve ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Department of Genetics ^*  (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Jackson State University   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Autism; Gene expression; Neuronal activity; Striatum; Ultrasonic vocalizations

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR FORKHEAD BOX P1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, HUMAN; FOXP1 PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN REGION; CELL ACTIVITY; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; EXCITABILITY; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; VOCALIZATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HAPLOINSUFFICIENCY; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERBAL BEHAVIOR;

ANIMALS; AUTISM SPECTRUM DISORDER; CELLS, CULTURED; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HAPLOINSUFFICIENCY; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MUTATION; NEURONS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; VERBAL BEHAVIOR;

EID: 84944753604     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.267989.115     Document Type: Article

References (81)

1. Ade KK, Wan Y, Chen M, Gloss B, Calakos N. 2011. An improved BAC transgenic fluorescent reporter line for sensitive and specific identification of striatonigral medium spiny neurons. Front Syst Neurosci 5: 32.
2. Agmon A, Connors BW. 1991. Thalamocortical responses of mouse somatosensory (barrel) cortex in vitro. Neuroscience 41: 365-379.
3. Anders S, Pyl PT, Huber W. 2014. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31: 166-169.
4. Bacon C, Rappold GA. 2012. The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Hum Genet 131: 1687-1698.
5. Bacon C, Schneider M, Le Magueresse C, Froehlich H, Sticht C, Gluch C, Monyer H, Rappold GA. 2015. Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour. Mol Psychiatry 20: 632-639.
6. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300.
7. Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, et al. 2008. Abnormal striatal GABA transmission in the mouse model for the Fragile X syndrome. Biol Psychiatry 63: 963-973.
8. Chien WH, Gau SS, Chen CH, Tsai WC, Wu YY, Chen PH, Shang CY, Chen CH. 2013. Increased gene expression of FOXP1 in patients with autism spectrum disorders. Mol Autism 4: 23.
9. Curry T, Egeto P, Wang H, Podnos A, Wasserman D, Yeomans J. 2013. Dopamine receptor D2 deficiency reduces mouse pup ultrasonic vocalizations and maternal responsiveness. Genes Brain Behav 12: 397-404.
10. Darnell JC, Klann E. 2013. The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 16: 1530-1536.
11. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, et al. 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247-261.
12. Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM. 2008. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 134: 304-316.
13. Deacon RM. 2006. Assessing nest building in mice. Nat Protoc 1: 1117-1119.
14. Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Penagarikano O, et al. 2015. Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Mol Psychiatry 20: 118-125.
15. Enard W, Gehre S, Hammerschmidt K, Holter SM, Blass T, Somel M, Bruckner MK, Schreiweis C, Winter C, Sohr R, et al. 2009. A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 137: 961-971.
16. Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA. 2003. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 460: 266-279.
17. Fisher SE, Scharff C. 2009. FOXP2 as a molecular window into speech and language. Trends Genet 25: 166-177.
18. Foeger NC, Norris AJ, Wren LM, Nerbonne JM. 2012. Augmentation of Kv4.2-encoded currents by accessory dipeptidyl peptidase 6 and 10 subunits reflects selective cell surface Kv4.2 protein stabilization. J Biol Chem 287: 9640-9650.
19. French CA, Jin X, Campbell TG, Gerfen E, Groszer M, Fisher SE, Costa RM. 2012. An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning. Mol Psychiatry 17: 1077-1085.
20. Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. Affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
21. Gerfen CR, Surmeier DJ. 2011. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34: 441-466.
22. Geschwind DH, State MW. 2015. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. doi: 10.1016/S1474-4422(15)00044-7.
23. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, et al. 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425: 917-925.
24. Grant LM, Richter F, Miller JE, White SA, Fox CM, Zhu C, Chesselet MF, Ciucci MR. 2014. Vocalization deficits in mice overexpressing α-synuclein, a model of pre-manifest Parkinson’s disease. Behav Neurosci 128: 110-121.
25. Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ. 2011. Fragile X mental retardation protein regulates protein expression and mRNAtranslation of the potassium channel Kv4.2. J Neurosci 31: 5693-5698.
26. Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suarez-Farinas M, Schwarz C, Stephan DA, Surmeier DJ, et al. 2008. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135: 738-748.
27. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
28. Hernandez RN, Feinberg RL, Vaurio R, Passanante NM, Thompson RE, Kaufmann WE. 2009. Autism spectrum disorder in Fragile X syndrome: a longitudinal evaluation. Am J Med Genet A 149A: 1125-1137.
29. Hisaoka T, Nakamura Y, Senba E, Morikawa Y. 2010. The forkhead transcription factors, Foxp1 and Foxp2, identify different subpopulations of projection neurons in the mouse cerebral cortex. Neuroscience 166: 551-563.
30. Holy TE, Guo Z. 2005. Ultrasonic songs of male mice. PLoS Biol 3: e386.
31. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A. 2006. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 7: 819-826.
32. Hu Z, Chang YC, Wang Y, Huang CL, Liu Y, Tian F, Granger B, Delisi C. 2013. VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic acids research 41: W225-W231.
33. Iossifov I, O’Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, et al. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515: 216-221.
34. Kaestner KH, Knochel W, Martinez DE. 2000. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142-146.
35. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, et al. 2011. Spatio-temporal transcriptome of the human brain. Nature 478: 483-489.
36. Kim J, Wei DS, Hoffman DA. 2005. Kv4 potassium channel subunits control action potential repolarization and frequencydependent broadening in rat hippocampal CA1 pyramidal neurones. J Physiol 569: 41-57.
37. Klassen T, Davis C, Goldman A, Burgess D, Chen T, Wheeler D, McPherson J, Bourquin T, Lewis L, Villasana D, et al. 2011. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 145: 1036-1048.
38. Konopka G, Bomar JM, Winden K, Coppola G, Jonsson ZO, Gao F, Peng S, Preuss TM, Wohlschlegel JA, Geschwind DH. 2009. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature 462: 213-217.
39. Konopka G, Wexler E, Rosen E, Mukamel Z, Osborn GE, Chen L, Lu D, Gao F, Gao K, Lowe JK, et al. 2012. Modeling the functional genomics of autism using human neurons. Mol Psychiatry 17: 202-214.
40. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma’ayan A. 2010. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26: 2438-2444.
41. Langfelder P, Horvath S. 2008.WGCNA: an R package forweighted correlation network analysis. BMC Bioinformatics 9: 559.
42. Langfelder P, Luo R, Oldham MC, Horvath S. 2011. Is my network module preserved and reproducible? PLoS Comput Biol 7: e1001057.
43. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
44. Lee H, Lin MC, Kornblum HI, Papazian DM, Nelson SF. 2014. Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation. Hum Mol Genet 23: 3481-3489.
45. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, et al. 2007. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176.
46. Li S, Weidenfeld J, Morrisey EE. 2004. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24: 809-822.
47. Maloney SE, Rieger MA, Dougherty JD. 2013. Identifying essential cell types and circuits in autism spectrum disorders. Int Rev Neurobiol 113: 61-96.
48. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, et al. 2008. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488.
49. Maze I, Chaudhury D, Dietz DM, Von Schimmelmann M, Kennedy PJ, Lobo MK, Sillivan SE, Miller ML, Bagot RC, Sun H, et al. 2014. G9a influences neuronal subtype specification in striatum. Nat Neurosci 17: 533-539.
50. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-seq. Nat Methods 5: 621-628.
51. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. 2008. Functional organization of the transcriptome in human brain. Nat Neurosci 11: 1271-1282.
52. Ouwenga RL, Dougherty J. 2015. Fmrp targets or not: long, highly brain-expressed genes tend to be implicated in autism and brain disorders. Mol Autism 6: 16.
53. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, Horvath S, Geschwind DH. 2013. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155: 1008-1021.
54. Parikshak NN, Gandal MJ, Geschwind DH. 2015. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet 16: 441-458.
55. Pietropaolo S, Delage P, Cayzac S, Crusio WE, Cho YH. 2011. Sexdependent changes in social behaviors in motor pre-symptomatic R6/1 mice. PLoS One 6: e19965.
56. Pollard KS, Dudoit S, Laan MJ. 2005. Multiple testing procedures: R multtest package and applications to genomics. In Bioinformatics and computational biology solutions using R and bioconductor (ed. Gentleman R, et al.), pp. 249-271. Springer, New York.
57. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
58. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. 1997. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8: 711-713.
59. Rousso DL, Gaber ZB, Wellik D, Morrisey EE, Novitch BG. 2008. Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron 59: 226-240.
60. Rousso DL, Pearson CA, Gaber ZB, Miquelajauregui A, Li S, Portera-Cailliau C, Morrisey EE, Novitch BG. 2012. Foxp-mediated suppression of N-cadherin regulates neuroepithelial character and progenitor maintenance in the CNS. Neuron 74: 314-330.
61. Roy S, Watkins N, Heck D. 2012. Comprehensive analysis of ultrasonic vocalizations in a mouse model of Fragile Xsyndrome reveals limited, call type specific deficits. PLoS One 7: e44816.
62. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P. 2010. Peak-Analyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 11: 415.
63. Scattoni ML, Crawley J, Ricceri L. 2009. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33: 508-515.
64. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, Elder GA, Schmeidler J, De Gasperi R, Sosa MA, Rabidou D, et al. 2005. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci 102: 9643-9648.
65. Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, Morrisey EE. 2007. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 134: 1991-2000.
66. Sia GM, Clem RL, Huganir RL. 2013. The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice. Science 342: 987-991.
67. Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, Vernes SC, Fisher SE, Ren B, Geschwind DH. 2007. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet 81: 1144-1157.
68. State MW, Sestan N. 2012. Neuroscience. The emerging biology of autism spectrum disorders. Science 337: 1301-1303.
69. Stein JL, de la orre-Ubieta L, Tian Y, Parikshak NN, Hernandez IA, Marchetto MC, Baker DK, Lu D, Hinman CR, Lowe JK, et al. 2014. A quantitative framework to evaluate modeling of cortical development by neural stem cells. Neuron 83: 69-86.
70. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, Paabo S, Tong H, Chen L. 2006. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14: 159-166.
71. Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C, Masliah E, Leavitt BR, Thomas EA. 2012. Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Hum Mol Genet 21: 3097-3111.
72. Teramitsu I, Kudo LC, London SE, Geschwind DH, White SA. 2004. Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. J Neurosci 24: 3152-3163.
73. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-seq. Bioinformatics 25: 1105-1111.
74. Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor JM, Ho J, Mombereau C, Brewer A, Lowy E, et al. 2011. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet 7: e1002145.
75. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380-384.
76. Wang B, Lin D, Li C, Tucker P. 2003. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 278: 24259-24268.
77. Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE, Tucker PW. 2004. Foxp1 regulates cardiac outflowtract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 131: 4477-4487.
78. Wang L, Wang S, Li W. 2012. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28: 2184-2185.
79. Xu X, Wells AB, O’Brien DR, Nehorai A, Dougherty JD. 2014. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 34: 1420-1431.
80. Zhang B, Horvath S. 2005.Ageneral framework forweighted gene co-expression network analysis. Stat Appl Genet Mol Biol doi: 10.2202/1544-6115.1128.
81. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-seq (MACS). Genome Biol 9: R137.